1. Home
  2. TCBX vs SAGE Comparison

TCBX vs SAGE Comparison

Compare TCBX & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCBX
  • SAGE
  • Stock Information
  • Founded
  • TCBX 2008
  • SAGE 2010
  • Country
  • TCBX United States
  • SAGE United States
  • Employees
  • TCBX N/A
  • SAGE N/A
  • Industry
  • TCBX Banks
  • SAGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • TCBX Finance
  • SAGE Health Care
  • Exchange
  • TCBX Nasdaq
  • SAGE Nasdaq
  • Market Cap
  • TCBX 454.9M
  • SAGE 415.0M
  • IPO Year
  • TCBX 2021
  • SAGE 2014
  • Fundamental
  • Price
  • TCBX $30.84
  • SAGE $6.62
  • Analyst Decision
  • TCBX Hold
  • SAGE Hold
  • Analyst Count
  • TCBX 4
  • SAGE 19
  • Target Price
  • TCBX $33.67
  • SAGE $9.88
  • AVG Volume (30 Days)
  • TCBX 75.0K
  • SAGE 934.8K
  • Earning Date
  • TCBX 04-23-2025
  • SAGE 04-29-2025
  • Dividend Yield
  • TCBX N/A
  • SAGE N/A
  • EPS Growth
  • TCBX 44.43
  • SAGE N/A
  • EPS
  • TCBX 2.95
  • SAGE N/A
  • Revenue
  • TCBX $172,270,000.00
  • SAGE $47,404,000.00
  • Revenue This Year
  • TCBX $17.61
  • SAGE $100.64
  • Revenue Next Year
  • TCBX $6.52
  • SAGE $70.19
  • P/E Ratio
  • TCBX $10.09
  • SAGE N/A
  • Revenue Growth
  • TCBX 17.40
  • SAGE N/A
  • 52 Week Low
  • TCBX $18.82
  • SAGE $4.62
  • 52 Week High
  • TCBX $39.45
  • SAGE $14.56
  • Technical
  • Relative Strength Index (RSI)
  • TCBX 53.43
  • SAGE 36.71
  • Support Level
  • TCBX $29.60
  • SAGE $6.70
  • Resistance Level
  • TCBX $31.15
  • SAGE $7.63
  • Average True Range (ATR)
  • TCBX 1.41
  • SAGE 0.28
  • MACD
  • TCBX 0.32
  • SAGE -0.09
  • Stochastic Oscillator
  • TCBX 87.55
  • SAGE 4.94

About TCBX Third Coast Bancshares Inc.

Third Coast Bancshares Inc is a bank holding company. It focuses on providing commercial banking solutions to small and medium-sized businesses and professionals with operations in its markets. The bank operates eleven branches in the Greater Houston, Dallas-Fort Worth, and Austin-San Antonio markets, and one branch in Detroit, Texas. The company operates through one segment, community banking, It generates the majority of its revenue from interest on loans, customer service, and loan fees.

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

Share on Social Networks: